N Brock
-
- Chemotherapy-induced organ toxicity mitigation 15
- Pharmaceutical Science top 2%
- Chemical Reactions and Isotopes 8
- Hematology top 5%
- Oncology top 5%
- Pharmacology top 5%
-
- Synthesis and biological activity 7
- Organophosphorus compounds synthesis 4
- Synthesis and Characterization of Heterocyclic Compounds 3
-
- Pharmaceutical studies and practices 4
-
- Acute Lymphoblastic Leukemia research 4
-
- Carcinogens and Genotoxicity Assessment 3
- Journals
- Journal of Cancer Research and Clinical Oncology (7 papers)Cancer (5 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (4 papers)
- Partner nations
- GermanyNetherlandsRussia
In The Last Decade
N Brock
74 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 118
- Pathology and Forensic Medicine 764
- Pharmaceutical Science 137
- Hematology 210
- Oncology 509
- Pharmacology 153
Countries citing papers authored by N Brock
This map shows the geographic impact of N Brock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Brock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Brock more than expected).
Fields of papers citing papers by N Brock
This network shows the impact of papers produced by N Brock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Brock. The network helps show where N Brock may publish in the future.
Co-authorship network
The 25 scholars most cited alongside N Brock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 28 | |
| 2 | 1989 | 2 | |
| 3 | Oxazaphosphorine cytostatics: past-present-future. Seventh Cain Memorial Award lecture. | 1989 | 93 |
| 4 | Treatment of advanced malignancies with ifosfamide under protection with mesna. | 1988 | 1 |
| 5 | 1988 | 20 | |
| 6 | 1987 | 20 | |
| 7 | 1985 | 23 | |
| 8 | 1984 | 1 | |
| 9 | 1984 | 42 | |
| 10 | [Autoradiographic studies on the protective effect of mesna in the urinary bladder mucosa of the rat during administration of cyclophosphamide (preliminary communication)]. | 1983 | 1 |
| 11 | 1983 | 63 | |
| 12 | Pharmacological and toxicological properties of azelastine, a novel antiallergic agent. | 1981 | 65 |
| 13 | [Pharmacokinetics of Uromitexan]. | 1981 | 6 |
| 14 | Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide. | 1976 | 25 |
| 15 | [Carcinogenic effects of anti neoplastic and immunosuppressive drugs]. | 1971 | 2 |
| 16 | 1964 | 18 | |
| 17 | [On the mechanism of action of stilbestrol diphosphate (honvan) in prostate carcinoma]. | 1960 | 2 |
| 18 | 1952 | 1 | |
| 19 | [Determination of the therapeutìc applications of drugs. On pharmacotherapy of oxyuriasis with pararosaniline derivatives II]. | 1951 | 3 |
| 20 | 1951 | 7 |
About N Brock
N Brock is a scholar working on Pharmaceutical Science, Pathology and Forensic Medicine, Biochemistry, Organic Chemistry and Cancer Research, having authored 76 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (15 papers), Chemical Reactions and Isotopes (8 papers), Synthesis and biological activity (7 papers), Organophosphorus compounds synthesis (4 papers), Pharmaceutical studies and practices (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Carcinogens and Genotoxicity Assessment (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (764 citations), Pharmaceutical Science (137 citations), Hematology (210 citations), Oncology (509 citations) and Pharmacology (153 citations). N Brock has collaborated with scholars based in Germany, Netherlands and Russia. Frequent co-authors include Jurij Stekar, Jörg Pohl, H. J. Hohorst, J. Pohl, Herbert Arnold, Hohorst Hj, W Scheef, H. O. Klein, Ulf Niemeyer and B Schneider. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Cancer, Naunyn-Schmiedeberg s Archives of Pharmacology, Die Naturwissenschaften and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.